A Novel Form of Arginine-Chitosan as Nanoparticles Efficient for siRNA Delivery into Mouse Leukemia Cells

The modification of chitosan (CS) has greatly expanded its application in the field of medicine. In this study, low-molecular-weight chitosan was modified with arginine (Arg) by a simple method. The identification by the Fourier transform infrared spectra (FTIR) showed that Arg was successfully cova...

Full description

Bibliographic Details
Main Authors: Jixian Luo, Jiangfeng Chen, Yan Liu, Yongji He, Wenjuan Dong
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/2/1040
_version_ 1797441656193024000
author Jixian Luo
Jiangfeng Chen
Yan Liu
Yongji He
Wenjuan Dong
author_facet Jixian Luo
Jiangfeng Chen
Yan Liu
Yongji He
Wenjuan Dong
author_sort Jixian Luo
collection DOAJ
description The modification of chitosan (CS) has greatly expanded its application in the field of medicine. In this study, low-molecular-weight chitosan was modified with arginine (Arg) by a simple method. The identification by the Fourier transform infrared spectra (FTIR) showed that Arg was successfully covalently attached to the CS. Interestingly, Arg-CS was identified as nanoparticles by atomic force microscopy (AFM) and transmission electron microscopy (TEM), whose particle size was 75.76 ± 12.07 nm based on Dynamic Light Scattering (DLS) characterization. Then, whether the prepared Arg-CS nanoparticles could encapsulate and deliver siRNA safely was investigated. Arg-CS was found to be able to encapsulate siRNAs in vitro via electrostatic interaction with siRNA; the Arg-CS/siRNA complex was safe for L1210 leukemia cells. Therefore, modification of chitosan by Arg produces novel nanoparticles to deliver siRNA into leukemia cells. This is the first time to identify Arg-CS as nanoparticles and explore their ability to deliver <i>Rhoa</i> siRNA into T-cell acute lymphoblastic leukemia (T-ALL) cells to advance therapies targeting Rhoa in the future.
first_indexed 2024-03-09T12:27:18Z
format Article
id doaj.art-f5ef024121374d589d25f934b767fca9
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T12:27:18Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-f5ef024121374d589d25f934b767fca92023-11-30T22:34:30ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-01242104010.3390/ijms24021040A Novel Form of Arginine-Chitosan as Nanoparticles Efficient for siRNA Delivery into Mouse Leukemia CellsJixian Luo0Jiangfeng Chen1Yan Liu2Yongji He3Wenjuan Dong4School of Life Science, Shanxi University, 92 Wucheng Road, Taiyuan 030006, ChinaSchool of Life Science, Shanxi University, 92 Wucheng Road, Taiyuan 030006, ChinaSchool of Life Science, Shanxi University, 92 Wucheng Road, Taiyuan 030006, ChinaInstitute of Functional Food of Shanxi, Shanxi Agricultural University, 79 Longcheng Street, Taiyuan 030031, ChinaInstitute of Environmental Science, Shanxi University, 92 Wucheng Road, Taiyuan 030006, ChinaThe modification of chitosan (CS) has greatly expanded its application in the field of medicine. In this study, low-molecular-weight chitosan was modified with arginine (Arg) by a simple method. The identification by the Fourier transform infrared spectra (FTIR) showed that Arg was successfully covalently attached to the CS. Interestingly, Arg-CS was identified as nanoparticles by atomic force microscopy (AFM) and transmission electron microscopy (TEM), whose particle size was 75.76 ± 12.07 nm based on Dynamic Light Scattering (DLS) characterization. Then, whether the prepared Arg-CS nanoparticles could encapsulate and deliver siRNA safely was investigated. Arg-CS was found to be able to encapsulate siRNAs in vitro via electrostatic interaction with siRNA; the Arg-CS/siRNA complex was safe for L1210 leukemia cells. Therefore, modification of chitosan by Arg produces novel nanoparticles to deliver siRNA into leukemia cells. This is the first time to identify Arg-CS as nanoparticles and explore their ability to deliver <i>Rhoa</i> siRNA into T-cell acute lymphoblastic leukemia (T-ALL) cells to advance therapies targeting Rhoa in the future.https://www.mdpi.com/1422-0067/24/2/1040chitosanargininemodificationsiRNAtransfection
spellingShingle Jixian Luo
Jiangfeng Chen
Yan Liu
Yongji He
Wenjuan Dong
A Novel Form of Arginine-Chitosan as Nanoparticles Efficient for siRNA Delivery into Mouse Leukemia Cells
International Journal of Molecular Sciences
chitosan
arginine
modification
siRNA
transfection
title A Novel Form of Arginine-Chitosan as Nanoparticles Efficient for siRNA Delivery into Mouse Leukemia Cells
title_full A Novel Form of Arginine-Chitosan as Nanoparticles Efficient for siRNA Delivery into Mouse Leukemia Cells
title_fullStr A Novel Form of Arginine-Chitosan as Nanoparticles Efficient for siRNA Delivery into Mouse Leukemia Cells
title_full_unstemmed A Novel Form of Arginine-Chitosan as Nanoparticles Efficient for siRNA Delivery into Mouse Leukemia Cells
title_short A Novel Form of Arginine-Chitosan as Nanoparticles Efficient for siRNA Delivery into Mouse Leukemia Cells
title_sort novel form of arginine chitosan as nanoparticles efficient for sirna delivery into mouse leukemia cells
topic chitosan
arginine
modification
siRNA
transfection
url https://www.mdpi.com/1422-0067/24/2/1040
work_keys_str_mv AT jixianluo anovelformofargininechitosanasnanoparticlesefficientforsirnadeliveryintomouseleukemiacells
AT jiangfengchen anovelformofargininechitosanasnanoparticlesefficientforsirnadeliveryintomouseleukemiacells
AT yanliu anovelformofargininechitosanasnanoparticlesefficientforsirnadeliveryintomouseleukemiacells
AT yongjihe anovelformofargininechitosanasnanoparticlesefficientforsirnadeliveryintomouseleukemiacells
AT wenjuandong anovelformofargininechitosanasnanoparticlesefficientforsirnadeliveryintomouseleukemiacells
AT jixianluo novelformofargininechitosanasnanoparticlesefficientforsirnadeliveryintomouseleukemiacells
AT jiangfengchen novelformofargininechitosanasnanoparticlesefficientforsirnadeliveryintomouseleukemiacells
AT yanliu novelformofargininechitosanasnanoparticlesefficientforsirnadeliveryintomouseleukemiacells
AT yongjihe novelformofargininechitosanasnanoparticlesefficientforsirnadeliveryintomouseleukemiacells
AT wenjuandong novelformofargininechitosanasnanoparticlesefficientforsirnadeliveryintomouseleukemiacells